Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Melaleuca Inc. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 examiners across 5 art units, indicating that each reported assignment is distinct in examiner and art-unit terms.
HOLT, ANDRIAE M is the busiest examiner with 1 pending matter. Counsel should preserve consistent biotechnology terminology across the portfolio, while developing separate claim and prior-art responses for each examination setting.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 5 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLT, ANDRIAE M | 1 | 49.5% | +23.0% |
| MERRIAM, ANDREW E | 1 | 28.3% | +33.9% |
| MATTHEWS, JOSEPH RICCI | 1 | — | — |
| STEINKE, SEAN JAMES | 1 | 12.5% | +42.9% |
| LAZARO, DOMINIC | 1 | 63.7% | +31.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18143799 | COMPOSITIONS CONTAINING COATED MINERALS OR MINERAL-AMINO ACID COMPLEXES | STEINKE, SEAN JAMES | 22d overdue |
| 19009392 | DIETARY COMPOSITIONS | HOLT, ANDRIAE M | — |
| 18654463 | DIETARY SUPPLEMENT COMPOSITIONS AND METHODS FOR THEIR USE IN POST-WORKOUT RECOVERY | MERRIAM, ANDREW E | — |
| 18654712 | COLLAGEN BEVERAGES AND METHODS OF MAKING AND USING | MATTHEWS, JOSEPH RICCI | — |
| 17565944 | BABY LOTION | LAZARO, DOMINIC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18143799 | COMPOSITIONS CONTAINING COATED MINERALS OR MINERAL-AMINO ACID COMPLEXES | STEINKE, SEAN JAMES | 22d overdue |
| 19009392 | DIETARY COMPOSITIONS | HOLT, ANDRIAE M | — |
| 18654463 | DIETARY SUPPLEMENT COMPOSITIONS AND METHODS FOR THEIR USE IN POST-WORKOUT RECOVERY | MERRIAM, ANDREW E | — |
| 17565944 | BABY LOTION | LAZARO, DOMINIC | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1791 | 1 |
| 1656 | 1 |
| 1619 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19009392 | DIETARY COMPOSITIONS | HOLT, ANDRIAE M | 1614 | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2025 |
| 18654463 | DIETARY SUPPLEMENT COMPOSITIONS AND METHODS FOR THEIR USE IN POST-WORKOUT RECOVERY | MERRIAM, ANDREW E | 1791 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18654712 | COLLAGEN BEVERAGES AND METHODS OF MAKING AND USING | MATTHEWS, JOSEPH RICCI | 1656 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18143799 | COMPOSITIONS CONTAINING COATED MINERALS OR MINERAL-AMINO ACID COMPLEXES | STEINKE, SEAN JAMES | 1619 | §102§103Other | Final Rejection | 22d overdue | Pending | May 05, 2023 |
| 17565944 | BABY LOTION | LAZARO, DOMINIC | 1611 | §103§112 | Final Rejection | — | Pending | Dec 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMelaleuca Inc. has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Andriae M Holt has the most, with 1 of Melaleuca Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
